Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | BCL2A1 |
| Upstream (Parents) |
|---|
| (<<) ARHGAP25 → BCL2A1 |
| (<<) CASP1 → BCL2A1 |
| (<<) CHST11 → BCL2A1 |
| (<<) CLEC2B → BCL2A1 |
| (<<) CORO1A → BCL2A1 |
| (<<) COTL1 → BCL2A1 |
| (<<) EPHA2 → BCL2A1 |
| (<<) IL6 → BCL2A1 |
| (<<) ISG20 → BCL2A1 |
| (<<) LPXN → BCL2A1 |
| (<<) MAP3K9 → BCL2A1 |
| (<<) MTSS1 → BCL2A1 |
| (<<) NFKBIE → BCL2A1 |
| (<<) PIK3CD → BCL2A1 |
| (<<) RAP1A → BCL2A1 |
| (<<) RPS6KA3 → BCL2A1 |
| (<<) SHFM1 → BCL2A1 |
| (<<) SMAD1 → BCL2A1 |
| (<<) TNFAIP3 → BCL2A1 |
| Downstream (Children) |
|---|
| BCL2A1 → ARSA (>>) |
| BCL2A1 → BLNK (>>) |
| BCL2A1 → CABC1 (>>) |
| BCL2A1 → DUSP2 (>>) |
| BCL2A1 → E2F2 (>>) |
| BCL2A1 → EHD1 (>>) |
| BCL2A1 → EPHB2 (>>) |
| BCL2A1 → FGFR3 (>>) |
| BCL2A1 → IL18 (>>) |
| BCL2A1 → IRF1 (>>) |
| BCL2A1 → KYNU (>>) |
| BCL2A1 → LTA4H (>>) |
| BCL2A1 → RAC2 (>>) |
| BCL2A1 → ST3GAL2 (>>) |
| BCL2A1 → STC2 (>>) |
| BCL2A1 → STK17A (>>) |
